Key result
Initiation or augmentation of antihypertensive treatment significantly decreased the prevalence of orthostatic hypotension in older adults (RR 0.39).
Why the study?
Physicians are concerned about causing orthostatic hypotension, making them hesitant to initiate or augment antihypertensive treatment in older adults with hypertension.
Does a change in antihypertensive treatment affect orthostatic hypotension prevalence and severity in older adults with hypertension?
Meta-Analysis (n=26,695)
Does a change in antihypertensive treatment affect orthostatic hypotension prevalence and severity in older adults with hypertension?
Relative Risk: 0.39 (95% CI 0.21–0.72)
p-value: p=<0.01
Initiation or augmentation of antihypertensive treatment in older adults decreases rather than increases the prevalence of orthostatic hypotension, suggesting that physician hesitancy to prescribe these medications due to OH concerns may be unfounded.
Initiating or augmenting antihypertensives may lower orthostatic hypotension prevalence in older adults; challenges treatment hesitancy and leaves open need for randomized trials.
Orthostatic hypotension (OH) is common in older adults with hypertension. Antihypertensive treatment (AHT) prevents cardio- and cerebrovascular events. However, physicians are concerned to cause OH, making them hesitant to initiate or augment AHT in older adults with hypertension. We systematically researched electronic databases for trials with older participants (≥65 years) with hypertension and OH assessment after initiating, discontinuing, or augmenting AHT. Study quality was assessed using the ROBINS-I tool. Meta-analyses on OH prevalence and postural blood pressure (BP) drop were performed. Twenty-five studies (26,695 participants) met inclusion criteria, of which fifteen could be included in the meta-analyses. OH prevalence decreased after AHT initiation or augmentation (risk ratio 0.39 (95 % CI = 0.21–0.72; I2 = 47 %; p < 0.01), n = 6 studies), but also after AHT discontinuation (risk ratio 0.39 (95 % CI = 0.28–0.55; I2 = 0 %; p < 0.01), n = 2 studies). Postural BP drop did not change after initiation or augmentation of AHT (mean difference 1.07 (95 % CI = -0.49–2.64; I2 = 92 %; p = 0.18), n = 11 studies). The main reason for ten studies not to be included in the meta-analyses was absence of baseline OH data. Most of these studies reported OH incidences between 0 and 2 %. Studies were heterogeneous in OH assessment methods (postural change, timing of BP measurements, and OH definition). Risk of bias was moderate to serious in twenty studies. Results suggest that AHT initiation or augmentation decreases OH prevalence, implying that the risk of inducing OH may be overestimated in current AHT decision-making in older adults. However, the overall low level of evidence and the finding that AHT discontinuation reduces OH prevalence limit firm conclusions at present and highlight an important research gap. Future AHT trials in older adults should measure OH in a standardized protocol, adhering to consensus guidelines to overcome these limitations.
No takes yet. Share an insight, caveat, or question.
Klop et al. (2024) conducted a meta-analysis in Hypertension (n=26,695). Antihypertensive treatment initiation or augmentation vs. Before treatment (baseline) was evaluated on Orthostatic hypotension prevalence (RR 0.39, 95% CI 0.21-0.72, p=<0.01). Initiation or augmentation of antihypertensive treatment significantly decreased the prevalence of orthostatic hypotension in older adults (RR 0.39).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: